by Integumen_1 | Apr 25, 2019 | Financials, Investors, Labskin, Labskin AI, StoerForMen, Updates
Turner Pope Investor Evening Integumen is pleased to announce that Gerry Brandon, the Company’s CEO, will be presenting at an investor evening hosted by Turner Pope Investments (TPI) Ltd, on Monday 13th May 2019. The event will be held in London, EC2 and will...
by Integumen_1 | Apr 25, 2019 | Labskin, StoerForMen, Updates
Labskin STOER study demonstrates 54% increase in skin hydration in 24 hours Promotion of new skin cells leaving fresher looking skin Launch of New Animal-Free Labskin Dandruff Test Integumen today announces the completion of development and launch of a new...
by Integumen_1 | Apr 12, 2019 | Financials, Labskin, Labskin AI, Updates
Proposed Placing and Subscription of £2.518m Acquisition, Placing & Subscription Integumen plc, (AIM: SKIN, is pleased to announce that the Company has conditionally agreed to acquire the entire issued share capital of RinoCloud Limited (“RinoCloud”), an...
by Integumen_1 | Mar 5, 2019 | Cellulac, Financials, Labskin, Updates
Labskin secures digital automation and integration through £400,000 Cellulac – Integumen deferred loan agreement Integumen plc (AIM: SKIN), is pleased to announce that the Company has entered into an agreement with Cellulac Limited to acquire hi-tech laboratory...
by Integumen_1 | Feb 20, 2019 | Cellulac, Innovenn, Labskin, StoerForMen
Labskin CBD tests show greater than 99% reduction in bacterial growth on human skin Integumen plc (AIM: SKIN) is pleased to announce a greater than 99% reduction of bacterial growth in preliminary results of four formulations, all of which include Cannabinoid (CBD)...
by Integumen_1 | Jan 7, 2019 | Cellulac, Financials, Innovenn, Labskin, StoerForMen, Updates
Restructuring is Accelerating Growth into 2019 Trading Update The Company is pleased to announce the positive results of major restructuring and accelerated growth in product sales and contract test services at Labskin (Innovenn Limited, a wholly-owned subsidiary of...
Recent Comments